PIERIS PHARMACEUTICALS, INC. Human Resources Contracts & Agreements
45 Contracts & Agreements
- Bonus & Incentive Agreements (15 contracts)
- Compensation Agreements (7)
- Consulting Agreements (5)
- Employment Agreements (11)
- Separation Agreements (5)
- Severance Agreements (2)
- Consulting Agreement, dated December 13, 2024, by and between Palvella Therapeutics, Inc. and Thomas Bures (Filed With SEC on December 16, 2024)
- Separation Agreement, dated December 13, 2024, between Pieris Pharmaceuticals, Inc. and Thomas Bures (Filed With SEC on December 16, 2024)
- Separation Agreement, dated December 13, 2024, between Pieris Pharmaceuticals, Inc. and Stephen A. Yoder (Filed With SEC on December 16, 2024)
- Palvella Therapeutics, Inc.'s 2024 Equity Incentive Plan (Filed With SEC on December 12, 2024)
- Separation Agreement by and between the Pieris Pharmaceuticals GmbH and Shane Olwill, Ph.D., dated as of July 23, 2024 (Filed With SEC on November 13, 2024)
- Severance Agreement, dated May 22, 2020, by and between Kathleen Goin and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Severance Agreement, dated May 22, 2020, by and between Kathleen A. McGowan and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Employment Agreement, dated May 20, 2020, by and between Wesley Kaupinen and Palvella Therapeutics, Inc (Filed With SEC on August 9, 2024)
- Amendment No. 1 to Palvella Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on August 9, 2024)
- Form of Non-Qualified Stock Option Agreement under the Palvella Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on August 9, 2024)
- Form of Incentive Stock Option Agreement under the Palvella Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on August 9, 2024)
- Palvella Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on August 9, 2024)
- Consulting Agreement by and between the Registrant and Ahmed Mousa, dated as of September 11, 2023 (Filed With SEC on November 14, 2023)
- Separation Agreement by and between the Registrant and Hitto Kaufmann, Ph.D., dated as of July 26, 2023 (Filed With SEC on November 14, 2023)
- Pieris Pharmaceutical, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan, as Amended (Filed With SEC on June 26, 2023)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 31, 2023)
- Separation Agreement by and between Pieris Pharmaceuticals, Inc. and Tim Demuth, M.D., dated as of August 4, 2022 (Filed With SEC on November 4, 2022)
- Pieris Pharmaceuticals, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on June 27, 2022)
- Employment Contract by and between Pieris Pharmaceuticals GmbH and Tim Demuth, M.D., Ph.D., dated as of August 1, 2021 (Filed With SEC on May 11, 2022)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 2, 2022)
- Employment Agreement by and between Pieris Pharmaceuticals, Inc. and Tom Bures, dated as of October 7, 2021 (Filed With SEC on November 2, 2021)
- Employment Agreement by and between Pieris Pharmaceuticals, Inc. and Ahmed Mousa, dated as of October 7, 2021 (Filed With SEC on November 2, 2021)
- Pieris Pharmaceuticals, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan, as Amended (Filed With SEC on June 29, 2021)
- Pieris Pharmaceuticals, Inc. 2020 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on June 29, 2020)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 13, 2020)
- Pieris Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 9, 2019)
- Pieris Pharmaceuticals, Inc. 2019 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on July 31, 2019)
- Non-Employee Director Compensation Policy, as amended (Filed With SEC on March 18, 2019)
- Pieris Pharmaceuticals, Inc. 2018 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on July 26, 2018)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 11, 2017)
- PIERIS PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on March 30, 2017)
- CONSULTING AGREEMENT (Filed With SEC on March 30, 2017)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 30, 2017)
- PIERIS PHARMACEUTICALS, INC. Stock Option Grant Notice Stock Option Grant under the Companys 2016 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on March 30, 2017)
- PIERIS PHARMACEUTICALS, INC. 2016 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN (Filed With SEC on July 1, 2016)
- PIERIS PHARMACEUTICALS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on May 12, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 13, 2015)
- CONSULTING AGREEMENT (Filed With SEC on December 18, 2014)
- Amendment to the Employment Agreement dated October 21, 2014 between (Filed With SEC on December 18, 2014)
- Amendment to the Employment Agreement dated January 28, 2013 between (Filed With SEC on December 18, 2014)
